Sollmann T (1917)

The crucial test of therapeutic evidence. JAMA 69:198-199.
In 1917 Thorkild Sollmann, in an editorial published in JAMA, drew attention to the poor quality of reports of clinical studies, and too close a relationship between researchers and those manufacturing and selling drugs.

Key passage(s)

Sollmann-1917-kp1 Sollmann-1917-kp2

Whole article


Torald Herman Sollmann 1874-1965


The editors are grateful to:

JAMA for allowing the James Lind Library to link to this and other articles of historical relevance (email to Iain Chalmers from Annette Flanagin, 29 August 2014).

Key articles

  • Altman DG, Simera I (2015).
    A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network.
  • Jefferson T (2019).
    Sponsorship bias in clinical trials – growing menace or dawning realisation?
  • Podolsky SH (2022).
    The (Harry) Gold Standard: angina, suggestion, and the path to the “double-blind” test and Clinical Pharmacology.

Other articles